Abingdon Health Plc (ABDX.L)

10,24 -0,01 (-0,05%) In data: 10:34AM BST. Mercato aperto.

Abingdon Health Plc

York Biotech Campus
Sand Hutton
York YO41 1LZ
United Kingdom
44 19 0440 6050
https://www.abingdonhealth.com

Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 84

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Chris Henry Francis Yates	CEO & Director	244k	N/D	1974
Laura Towse	Group Financial Controller	N/D	N/D	N/D
Mr. Mark Jones	Chief Operating Officer	N/D	N/D	N/D
Ms. Brenda Hogan	HR Director	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in GBp.

Descrizione

Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays. It also offers AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader; and Salistick, a rapid saliva-based pregnancy test. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it offers regulatory consultancy services for businesses in the diagnostics sector. The company has a strategic collaboration with DeepVerge plc for the development, manufacturing, and commercialization of lateral flow tests; and Vatic Health Limited for the development, manufacturing, and commercialization of infectious disease lateral flow self-tests. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Governance aziendale

L'ISS Governance QualityScore di Abingdon Health Plc al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.